Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Calcitriol vs Alfacalcidol for Secondary Hyperparathyroidism in Hemodialysis
NCT01115543Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alfacalcidol in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Mahidol University. Primary endpoint: Reduction of intact parathyroid hormone levels at 48 weeks. Started Aug 2008; status: completed.
02
Drugs
alfacalcidol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT01115543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115543.